Loading...

Carter Barger, PhD

Title(s)Postdoctoral Scholar, Neurological Surgery
SchoolSchool of Medicine
Address1450 Third St
San Francisco CA 94158
Phone415-514-1183
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Nebraska Medical Center, Omaha, NEPhD2018Cancer Biology
    Rush University, Chicago, ILMS2008Clinical Laboratory Sciences
    University of Iowa, Iowa City, IABS2005Microbiology

    Collapse Research 
    Collapse Research Activities and Funding
    FOXM1-RHNO1 Oncogenic Axis in Ovarian Cancer
    NIH/NCI K00CA212470Aug 1, 2018 - Jul 31, 2022
    Role: Principal Investigator
    FOXM1-RHNO1 Oncogenic Axis in Ovarian Cancer
    NIH/NCI F99CA212470Sep 21, 2016 - Aug 31, 2018
    Role: Principal Investigator
    Forkhead Box M1 (FOXM1) in High Grade Serous Ovarian Cancer
    University of Nebraska University of Nebraska Presidential Graduate FelloAug 1, 2016 - Jul 31, 2017
    Role: Principal Investigator
    Forkhead Box M1 (FOXM1) in High Grade Serous Ovarian Cancer
    University of Nebraska Medical Center UNMC Program of Excellence FellowshipAug 1, 2015 - Jul 31, 2016
    Role: Principal Investigator
    Cancer Biology Training Program
    NIH/NCI T32CA009476Jun 1, 2013 - May 31, 2014
    Role: Trainee

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 2020 Jun 23; 11(25):2462-2463. Robb CM, Kour S, Contreras JI, Agarwal E, Barger CJ, Rana S, Sonawane Y, Neilsen BK, Taylor M, Kizhake S, Thakare RN, Chowdhury S, Wang J, Black JD, Hollingsworth MA, Brattain MG, Natarajan A. PMID: 32637035.
      View in: PubMed   Mentions:    Fields:    
    2. Global DNA Hypomethylation in Epithelial Ovarian Cancer: Passive Demethylation and Association with Genomic Instability. Cancers (Basel). 2020 Mar 24; 12(3). Zhang W, Klinkebiel D, Barger CJ, Pandey S, Guda C, Miller A, Akers SN, Odunsi K, Karpf AR. PMID: 32213861.
      View in: PubMed   Mentions:
    3. CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax. Mol Pharmacol. 2019 10; 96(4):419-429. Kour S, Rana S, Contreras JI, King HM, Robb CM, Sonawane YA, Bendjennat M, Crawford AJ, Barger CJ, Kizhake S, Luo X, Hollingsworth MA, Natarajan A. PMID: 31467029.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    4. NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma. Cancers (Basel). 2019 Aug 06; 11(8). Haque M, Li J, Huang YH, Almowaled M, Barger CJ, Karpf AR, Wang P, Chen W, Turner SD, Lai R. PMID: 31390744.
      View in: PubMed   Mentions:
    5. BORIS Expression in Ovarian Cancer Precursor Cells Alters the CTCF Cistrome and Enhances Invasiveness through GALNT14. Mol Cancer Res. 2019 10; 17(10):2051-2062. Hillman JC, Pugacheva EM, Barger CJ, Sribenja S, Rosario S, Albahrani M, Truskinovsky AM, Stablewski A, Liu S, Loukinov DI, Zentner GE, Lobanenkov VV, Karpf AR, Higgins MJ. PMID: 31292201.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    6. Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer. Cancers (Basel). 2019 Feb 21; 11(2). Barger CJ, Branick C, Chee L, Karpf AR. PMID: 30795624.
      View in: PubMed   Mentions:
    7. Expression of the POTE gene family in human ovarian cancer. Sci Rep. 2018 11 20; 8(1):17136. Barger CJ, Zhang W, Sharma A, Chee L, James SR, Kufel CN, Miller A, Meza J, Drapkin R, Odunsi K, Klinkebiel D, Karpf AR. PMID: 30459449.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    8. Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 2018 Jan 12; 9(4):5216-5232. Robb CM, Kour S, Contreras JI, Agarwal E, Barger CJ, Rana S, Sonawane Y, Neilsen BK, Taylor M, Kizhake S, Thakare RN, Chowdhury S, Wang J, Black JD, Hollingsworth MA, Brattain MG, Natarajan A. PMID: 29435174.
      View in: PubMed   Mentions: 3     Fields:    
    9. PRAME expression and promoter hypomethylation in epithelial ovarian cancer. Oncotarget. 2016 Jul 19; 7(29):45352-45369. Zhang W, Barger CJ, Eng KH, Klinkebiel D, Link PA, Omilian A, Bshara W, Odunsi K, Karpf AR. PMID: 27322684.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    10. Protein Kinase Ca (PKCa) Is Resistant to Long Term Desensitization/Down-regulation by Prolonged Diacylglycerol Stimulation. J Biol Chem. 2016 Mar 18; 291(12):6331-46. Lum MA, Barger CJ, Hsu AH, Leontieva OV, Black AR, Black JD. PMID: 26769967.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    11. Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression. Oncotarget. 2015 Sep 29; 6(29):27613-27. Barger CJ, Zhang W, Hillman J, Stablewski AB, Higgins MJ, Vanderhyden BC, Odunsi K, Karpf AR. PMID: 26243836.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    12. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer. Epigenetics. 2015; 10(8):736-48. Zhang W, Barger CJ, Link PA, Mhawech-Fauceglia P, Miller A, Akers SN, Odunsi K, Karpf AR. PMID: 26098711.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    13. PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients. Int J Cancer. 2010 Apr 01; 126(7):1630-9. Buckingham L, Penfield Faber L, Kim A, Liptay M, Barger C, Basu S, Fidler M, Walters K, Bonomi P, Coon J. PMID: 19795445.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells